FDA Inspection 1051035 — Woodland International Research Group, Inc.
The FDA completed an inspection of Woodland International Research Group, Inc. on March 8, 2018 in Little Rock, AR. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 8, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Little Rock, AR (United States)
Additional Details
Clinical BA/BE